Are you a Health Professional? Jump over to the doctors only platform. Click Here

Renal Safety of Zoledronic Acid in Patients with Breast Cancer

Zoledronic acid was found to have a renal safety profile comparable to that of pamidronate in patients with breast cancer. No patient with breast cancer treated with zoledronic acid was found to have experienced a NCI Common Toxicity Criteria of grade 3 or 4 serum creatinine increase.

To view the full article please click here.


Dates

Posted On: 7 November, 2005
Modified On: 20 March, 2014

Tags



Created by: myVMC